2017
DOI: 10.1016/j.freeradbiomed.2017.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic hypoxia-inducible factors inhibit PPARα expression to exacerbate acetaminophen induced oxidative stress and hepatotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
28
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 46 publications
0
28
0
Order By: Relevance
“…On the other hand, administration of APAP to mice induces malondialdehyde and myeloperoxidase formation and decreases in hepatic levels of SOD and glutathione, which aggravates oxidative damage to further lead to liver tissue damage ( Wu et al, 2017 ). To date, the consensus of opinion is that the metabolite of APAP results in depletion of GSH and formation of GSSG that contributes to cause mitochondrial oxidant stress and ultimately promote liver injury ( Li et al, 2017 ). In addition, previous abundant researches indicated that APAP-induced hepatic structural integrity by displaying serious destruction of hepatic architecture, necrosis, and infiltration of inflammatory cells ( Hasanein and Sharifi, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, administration of APAP to mice induces malondialdehyde and myeloperoxidase formation and decreases in hepatic levels of SOD and glutathione, which aggravates oxidative damage to further lead to liver tissue damage ( Wu et al, 2017 ). To date, the consensus of opinion is that the metabolite of APAP results in depletion of GSH and formation of GSSG that contributes to cause mitochondrial oxidant stress and ultimately promote liver injury ( Li et al, 2017 ). In addition, previous abundant researches indicated that APAP-induced hepatic structural integrity by displaying serious destruction of hepatic architecture, necrosis, and infiltration of inflammatory cells ( Hasanein and Sharifi, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…We do not have an explanation for the differential rescuing action of 2-ME on the expression of the three CYP isoforms studied. We propose that hypoxia induces HIF-1α-dependent transcriptional repression of CYP2B6, CYP3A4 and CYP3A5; however, our results do not discard additional HIF-1α-independent regulatory mechanisms, including the activation of transcriptional repressors such as the small heterodimer partner (SHP), which has been implicated in the inhibition of the CYP7A1 isoform under hypoxic conditions, and the downregulation of nuclear receptors implicated in the positive regulation of CYP2B6, CYP3A4 and CYP3A5, namely PPARα, PPARγ or ER-α, as well as the constitutive androstane and pregnane X receptors, whose mRNA was found to be reduced by hypoxia (1% O 2 , 24 h) in hepatic HepaRG stem cells ( 21 , 51 , 52 , 63 – 65 ) In addition, post-transcriptional regulation of CYP expression implicates the action of diverse mRNA stabilizing molecules, microRNAs and long noncoding RNAs ( 66 ). Finally, 2-ME itself could act as a chemical modulator of CYP expression, because CYP substrates or their metabolites are capable of inducing CYP expression ( 19 ).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that HIF-1α protein synthesis was regulated through the PI3K/AKT and MAPK pathways, and its expression is regarded as the suppression factor for HIF-1 DNA binding and transcriptional activities in many cultured cells ( Frede et al, 2006 ; Olson and van der Vliet, 2011 ; Yu et al, 2012 ). Another studies also demonstrated that HIF-1α contributes to the development of myeloid cell–mediated inflammation, facilitates the phagocytic function of macrophages and exacerbates the acetaminophen-induced oxidative stress and hepatotoxicity ( Cramer et al, 2003 ; Peyssonnaux et al, 2005 ; Li et al, 2017 ). Recently, HIF-1α was demonstrated to be increased in the lungs of COPD patients and activation of HIF-1α signaling pathway by cigarette smoke (CS), a key pathological driver of COPD, accelerates the development of COPD ( Ding et al, 2015 ; Baz-Davila et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%